Test Module 2

The second edition provides an improved basis for policy debate and informed decision-making at a critical time for global health.

Roles: Everyone: All Users

Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation

• Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)
• The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic 
  
• Interest from governments represen

  Roles: Everyone: All Users

  Regions: Argentina, Canada , Norway , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• Addressing the crisis in antibiotic development

  Today, more than 20 leading biopharmaceutical companies are announcing the launch of the AMR Action Fund that will invest in developing innovative antibacterial treatments. The Fund aims to bring 2-4 new treatments to patients by 2030. This initiative is a significant step towards addressing the current crisis in antibacterial treatment development.

  Joint Leader's statement - Violence against children: A hidden crisis of the COVID-19 pandemic